Physician profile

Yumna Saeed

Sleep Medicine (Psychiatry & Neurology) · Bloomington, MN

NPI 1982970463

$681.68

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Sleep Medicine (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$345.34

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Tg Therapeutics, INC. $187.89 2023
Abbvie INC. $176.23 2021-2023 Botox
Biogen, INC. $134.80 2022-2023 Tysabri, Vumerity
Novartis Pharmaceuticals Corporation $88.40 2020
Allergan, INC. $27.41 2020
Livanova USA, INC. $27.03 2022
Inspire Medical Systems, INC. $20.71 2023 Inspire
Abbott Laboratories $19.21 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Yumna Saeed

$681.68

in general payments reported 2019-2025

Years
2020-2023
Top company
Tg Therapeutics, INC.

https://glasscript.com/doctor/3589092/yumna-saeed

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.